CCRA Clinical Trial Monitoring Techniques 2

Question 1

Centralized monitoring differs from on-site monitoring in that it:

Accepted Answer

Involves remote review of accumulating data to identify trends and signals

Answer

Centralized monitoring uses statistical analysis and remote data review to detect data anomalies, enrollment patterns, and compliance signals without requiring a site visit.

Question 2

Which of the following is an example of a critical process that should be prioritized during risk-based monitoring?

Accepted Answer

Informed consent process and documentation

Answer

The informed consent process is a critical process because failures directly affect subject rights and can invalidate subject participation from a regulatory standpoint.

Question 3

A 'trigger' in risk-based monitoring refers to:

Accepted Answer

The signal that prompts an unplanned site visit or escalated review based on predefined thresholds

Answer

Triggers are predefined thresholds or signals (e.g., high query rate, low consent rate) that prompt escalated monitoring actions such as additional on-site or centralized review.

Question 4

At a Site Closeout Visit (COV), which activity is MOST critical for the CRA to confirm?

Accepted Answer

All trial materials are accounted for and essential documents are complete and archived

Answer

During closeout, the CRA must ensure all investigational product is reconciled, essential documents are complete, and the site understands retention requirements for regulatory inspection readiness.

Question 5

When performing source document verification, the CRA confirms that source data is ALCOA+. What does 'ALCOA' stand for?

Accepted Answer

Attributable, Legible, Contemporaneous, Original, Accurate

Answer

ALCOA stands for Attributable, Legible, Contemporaneous, Original, and Accurate — the five core data quality attributes required for clinical trial data.

CCRA - Certified Clinical Research Associate Practice Test

CCRA - Certified Clinical Research Associate Practice Test

CCRA Clinical Trial Monitoring Techniques 2